Frontiers in Immunology (Sep 2022)

Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers – ORCHESTRA project

  • Giulia Collatuzzo,
  • Giovanni Visci,
  • Francesco S. Violante,
  • Stefano Porru,
  • Gianluca Spiteri,
  • Maria Grazia Lourdes Monaco,
  • Francesca Larese Fillon,
  • Corrado Negro,
  • Christian Janke,
  • Noemi Castelletti,
  • Giuseppe De Palma,
  • Emanuele Sansone,
  • Dana Mates,
  • Silvia Teodorescu,
  • Eleonóra Fabiánová,
  • Jana Bérešová,
  • Luigi Vimercati,
  • Silvio Tafuri,
  • Mahsa Abedini,
  • Giorgia Ditano,
  • Shuffield S. Asafo,
  • Paolo Boffetta,
  • Paolo Boffetta,
  • Orchestra WP5 Working Group,
  • Carlotta Zunarelli,
  • Roberta Bonfiglioli,
  • Angela Carta,
  • Giuseppe Verlato,
  • Giuseppe Lippi,
  • Davide Gibellini,
  • Maria Diletta Pezzani,
  • Lorena Torroni,
  • Michael Hoelscher,
  • Andreas Wieser,
  • Christina Reinkemeyer,
  • Michael Plank,
  • Ivan Noreña,
  • Raquel Rubio-Acero,
  • Simon Winter,
  • Mihaela Leustean,
  • Ovidiu Perseca,
  • Madalina Ipate,
  • Agripina Rascu,
  • Jozef Strhársky,
  • Petra Hellebrandt,
  • Daniela Križanová,
  • Marianna Mrázová,
  • Luigi De Maria,
  • Stefania Sponselli,
  • Pasquale Stefanizzi,
  • Antonio Caputi

DOI
https://doi.org/10.3389/fimmu.2022.986085
Journal volume & issue
Vol. 13

Abstract

Read online

BackgroundThe duration of immune response to COVID-19 vaccination is of major interest. Our aim was to analyze the determinants of anti-SARS-CoV-2 IgG titer at 6 months after 2-dose vaccination in an international cohort of vaccinated healthcare workers (HCWs).MethodsWe analyzed data on levels of anti-SARS-CoV-2 Spike antibodies and sociodemographic and clinical characteristics of 6,327 vaccinated HCWs from 8 centers from Germany, Italy, Romania and Slovakia. Time between 1st dose and serology ranged 150-210 days. Serological levels were log-transformed to account for the skewness of the distribution and normalized by dividing them by center-specific standard errors, obtaining standardized values. We fitted center-specific multivariate regression models to estimate the cohort-specific relative risks (RR) of an increase of 1 standard deviation of log antibody level and corresponding 95% confidence interval (CI), and finally combined them in random-effects meta-analyses.ResultsA 6-month serological response was detected in 99.6% of HCWs. Female sex (RR 1.10, 95%CI 1.00-1.21), past infection (RR 2.26, 95%CI 1.73-2.95) and two vaccine doses (RR 1.50, 95%CI 1.22-1.84) predicted higher IgG titer, contrary to interval since last dose (RR for 10-day increase 0.94, 95%CI 0.91-0.97) and age (RR for 10-year increase 0.87, 95%CI 0.83-0.92). M-RNA-based vaccines (p<0.001) and heterologous vaccination (RR 2.46, 95%CI 1.87-3.24, one cohort) were associated with increased antibody levels.ConclusionsFemale gender, young age, past infection, two vaccine doses, and m-RNA and heterologous vaccination predicted higher antibody level at 6 months. These results corroborate previous findings and offer valuable data for comparison with trends observed with longer follow-ups.

Keywords